US Stock MarketDetailed Quotes

CLDX Celldex Therapeutics

Watchlist
  • 34.180
  • +1.080+3.26%
Close Aug 16 16:00 ET
  • 34.180
  • 0.0000.00%
Post 16:52 ET
2.27BMarket Cap-12429P/E (TTM)

Celldex Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Celldex Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 1.061M--
--2024/Q3-- / 1.074M--
--2024/Q22.498M / 854.290K--
--2024/Q1156.000K / 816.670K--
Feb 26, 20242023/Q44.132M / 855.710K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 1.061M--
--2024/Q3-- / 1.074M--
--2024/Q22.498M / 854.290K--
--2024/Q1156.000K / 816.670K--
Feb 26, 20242023/Q44.132M / 855.710K--

Unlock Free Earnings Estimates

Celldex Therapeutics Earnings Reports

  • Celldex Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 16:57 ET

  • Celldex Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 6 16:13 ET

  • Celldex Therapeutics | 10-K: FY2023 Annual Report

    Feb 26 07:10 ET

  • Celldex Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 16:06 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 12, 2024

    Strong Buy

    • Buy

      85.71%

    • Hold

      14.29%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg